Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI

ClinicalTrials.gov ID: NCT02901717

Public ClinicalTrials.gov record NCT02901717. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 17, 2026, 10:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Efficacy and Safety of Mino-Lok Therapy (MLT) in Combination With Systemic Antibiotics in the Treatment of Catheter-Related or Central Line-Associated Bloodstream Infection

Study identification

NCT ID: NCT02901717
Recruitment status: Not listed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Leonard-Meron Biosciences, Inc.; Industry
Enrollment: 144 participants

Conditions and interventions

Conditions

Catheter-related Infections

Interventions

Antibiotic lock Drug
Mino-Lok Drug

Drug

Eligibility (public fields only)

Age range: 12 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Feb 12, 2018
Primary completion: Nov 30, 2022
Completion: Feb 28, 2023
Last update posted: Apr 18, 2022

2018 – 2023

United States locations

U.S. sites: 19
U.S. states: 16
U.S. cities: 19

Facility	City	State	ZIP	Site status
Georgetown University Hospital	Washington D.C.	District of Columbia	20007	Recruiting
University of Florida Shands Hospital	Gainesville	Florida	32608	Recruiting
Edward Hines Jr. VA Hospital	Hines	Illinois	60141	Recruiting
AMG Oncology	Park Ridge	Illinois	60068	Recruiting
Indiana Blood and Marrow Institute	Indianapolis	Indiana	46237	Recruiting
Ascension Via Christi Hospital	Wichita	Kansas	67214	Recruiting
University of Kentucky Medical Center	Lexington	Kentucky	40536	Suspended
Anne Arundel Medical Center	Annapolis	Maryland	21401	Suspended
Massachusetts General Hospital	Boston	Massachusetts	02114	Recruiting
Henry Ford Health Systems	Detroit	Michigan	48202	Recruiting
William Beaumont Hospital	Troy	Michigan	48083	Suspended
VA Sierra Nevada Health Care Systems	Reno	Nevada	89502	Recruiting
Saint Michael's Medical Center	Newark	New Jersey	07102	Recruiting
Carolinas Medical Center	Charlotte	North Carolina	28203	Recruiting
East Carolina University	Greenville	North Carolina	27858	Recruiting
University Hospitals Cleveland Medical Center	Cleveland	Ohio	44106	Recruiting
University of Texas MD Anderson Cancer Center	Houston	Texas	77030	Recruiting
Salem VA Medical Center	Salem	Virginia	24153	Recruiting
Seattle Children's Hospital	Seattle	Washington	98105	Suspended

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02901717, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 18, 2022 · Synced May 17, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02901717 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →